<DOC>
	<DOCNO>NCT01280045</DOCNO>
	<brief_summary>The investigator aim assess use aromatase inhibitor could decrease volume uterine leiomyoma cause percentage adverse effect use compare GnRH analog .</brief_summary>
	<brief_title>Influence Aromatase Inhibitors GnRH Analogs Treat Uterine Leiomyoma Vaginal Hysterectomy</brief_title>
	<detailed_description>Uterine leiomyoma prevalent benign gynecologic tumor woman . Standard treatment surgical ( hysterectomy myomectomy ) , depend many variable . If tumor large , preoperative assessment clinical treatment may useful order decrease volume , improve hematologic pattern modify surgical approach ( vaginal abdominal ) . It well know GnRH analog cause goal ; however , aromatase inhibitor new promise drug use reduce uterine leiomyoma 's volume observational study show fact . The investigator aim compare treatment randomize controlled trial see treatment similar decrease uterine leiomyoma 's volume , influence operative time , blood loss surgery .</detailed_description>
	<mesh_term>Leiomyoma</mesh_term>
	<mesh_term>Myofibroma</mesh_term>
	<mesh_term>Aromatase Inhibitors</mesh_term>
	<criteria>WOMEN OVER 40 YEARS , UTERINE VOLUME HIGHER THAN 300 ML , MINIMAL ANATOMIC CONDITIONS FOR VAGINAL SURGERY ACTIVE GYNECOLOGIC MALIGNANCY</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>May 2012</verification_date>
</DOC>